Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

NCT05435053 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped The study was terminated on the basis on an evaluation of the safety and efficacy of the 9 included patients of which 2 of the patients were excluded before receiving any study treatments, thus 7 patients were treated in the study.

Conditions

Interventions

Sponsor

Ismail Gögenur